PR-N acknowledges support from Le Fonds de recherche du Qu??bec – Sant?? chercheurs-boursiers program, the Canadian Institutes of Health Research, the Alzheimer’s Association and the Aisenstadt Foundation. Declarations This article has been published as part of Alzheimer’s Research & Therapy Volume 5 Supplement www.selleckchem.com/products/Roscovitine.html 1, 2013: Background documents to the 4th Canadian Consensus Conference on the Diagnosis and Treatment of Dementia (CCCDTD4). The full contents of the supplement are available online at http://alzres.com/supplements/5/S1. Publication charges for the supplement were funded by the Canadian Consensus Conference on the Diagnosis and Treatment of Dementia (CCCDTD). Although residual conference funds used include contributions from pharmaceutical companies, no commercial organization has been involved in the selection of participants, choice of topics, preparation of background papers or recommendations.

In kind support was also provided by the Canadian Dementia Knowledge Translation Network, and the offices of Drs Serge Gauthier (McGill University), Christopher Patterson (McMaster University) and Howard Chertkow (McGill University), whose role as Guest Editors involved the coordination of the project without involvement in the journal’s standard peer review process which applied for all articles.
The growing population of persons with dementia in Canada and the provision of quality care for this population is an issue that no healthcare authority will escape. Physicians often view dementia as a difficult and time-consuming condition to diagnose and manage [1-3].

Current evidence must be effectively transformed into usable recommendations for physicians; however, we know that use of evidence-based practice recommendations is a challenge in all realms of medical care, and failure to utilize these leads to less Cilengitide than optimal care for patients [4-7]. This is no different in dementia care, where physicians often perceive a lack of recommendations even when these exist [8]. While continuing professional development (CPD) and continuing medical education (CME) have traditionally attempted to address this need for effective implementation of recommendations, increasingly it is knowledge translation (KT) – with its focus on health outcomes, interdisciplinary approach, and broad outlook which encompasses and expands on many of the concepts of CPD and CME – that is being called upon to improve the use of evidence in practice [5]. Despite this growing emphasis, KT often appears on the surface to be a daunting topic. Over 90 terms have been coined to describe KT [9,10] and there are a variety of theories and selleck chem implementation frameworks for an individual researcher or group to choose from when considering the use of KT.